Amarin | AMRN - Current Assets

Stock Price
14.89
Daily Change
-0.11 -0.73%
Monthly
10.26%
Yearly
34.71%
Q1 Forecast
14.47

Amarin reported $628.33M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Alnylam Pharmaceuticals USD 3.95B 309.11M Sep/2025
Amarin USD 628.33M 21.52M Sep/2025
AstraZeneca USD 29.94B 1B Sep/2025
DBV Technologies USD 88.88M 32.36M Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
Neurocrine Biosciences USD 2.16B 409.5M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025